Dose-Related Prolongation of Ropivacaine Epidural Anesthesia by Epidural Ketamine

로피바카인 경막외 마취 시 케타민첨가 용량에 따른 마취시간의 연장

  • Joo, Jin Deok (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Jeon, Yeon Su (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Choi, Jin Woo (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • In, Jang Hyeok (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Yong Shin (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kang, Yoo Jin (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Dae Woo (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lim, Yong Gul (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Ghi Hyun (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea)
  • 주진덕 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 전연수 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 최진우 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 인장혁 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 김용신 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 강유진 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 김대우 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 임용걸 (가톨릭대학교 의과대학 마취통증의학교실) ;
  • 김기현 (가톨릭대학교 의과대학 마취통증의학교실)
  • Received : 2005.03.03
  • Accepted : 2005.06.10
  • Published : 2005.06.30

Abstract

Background: Besides its general anesthetic effect, ketamine interacts with sodium channels in a local anesthetic-like fashion, including the sharing of binding sites with those commonly used by clinical local anesthetics. This study evaluated the dose related effects of ketamine during epidural anesthesia with 0.5% ropivacaine. Methods: Sixty ASA physical status I II patients, scheduled for minor elective surgery under epidural anesthesia using 0.5% ropivacaine, were randomly divided into three groups (n = 20 each). The patients initially received either 0.5% ropivacaine (group 1), ketamine (0.1 mg/kg) in addition to the epidural 0.5% ropivacaine (group 2) or ketamine (0.2 mg/kg) in addition to the epidural 0.5% ropivacaine (group 3). The regression of sensory block was assessed by transcutaneous electric stimulation (TES), equivalent to a surgical incision. Motor block was assessed using the Modified Bromage's scale. Episodes of bradycardia, hypotension and sedation were also recorded. Results: There were no significant differences among the three groups in the maximal levels of sensory block or the times taken for these levels to be reached. The mean times for the block to regress to two and four segments below the maximal level were significantly prolonged by epidural ketamine. Conclusions: Epidural ketamine prolongs the duration of ropivacaine epidural anesthesia. These results suggest that ketamine has local anesthetic-like actions.

Keywords

References

  1. Yang CY, Wong CS, Chang JY, Ho ST: Intrathecal kerarnine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 1996; 43: 379-83. https://doi.org/10.1007/BF03011718
  2. Joo JD, Kim DW, Kang Y]: Low-dose ketamine and midazolam as an adjuvant to iv morphine for control of pain in cancer terminal life care. Korean J Pain 2003; 16: 79-83.
  3. Gertud H, Diana T, Johannes B, Reinhard D, Sinikka M, Harrrnur H, et al: Blockade of voltage-operated neuronal and skeletal muscle sodium channels by S(+)- and R(-)- kerarnine. Anesth Analg 2003;96: 1019-26.
  4. Wagner LE, Gingrich KJ, Kulli JC, Yang]: Ketamine blockade of voltage-gated sodium channels; Evidence for a shared receptor site with local anesthetics. Anesthesiology 2001; 95: 1406-13.
  5. White PF, Way WL, Trevor AJ: Keramine-its pharmacology and therapeutic uses. Anesthesiology 1982; 56: 119-36. https://doi.org/10.1097/00000542-198202000-00007
  6. Schmid RL, Sandler AN, Katz]: Use and efficacy of low dose ketamine in management of acute postoperative pain. Pain 1999; 82:111-25. https://doi.org/10.1016/S0304-3959(99)00044-5
  7. Meller ST: Ketarnine: relief from chronic pain through actions at the NMDA receptor? Pain 1996; 68: 435-6.
  8. Woolf C], Thompson SW: The induction and maintenance of central sensitization is dependant on the N-methyl-D-aspartic acid receptor activation; implication for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293-9.
  9. Islas JA, Astorga J, Laredo M: Epidural ketamine for control of postoperative pain. Anesth Analg 1985; 64: 1161-2.
  10. Peat SJ, Bras P, Hanna MH: A double-blind comparison epidural ketamine and diamorphine for postoperative analgesia. Anaesthesia 1989; 44: 555-8. https://doi.org/10.1111/j.1365-2044.1989.tb11440.x
  11. Bion JF: Intrathecal ketamine for war surgery: a preliminary study under field conditions. Anaesthesia 1984; 39: 1023-8. https://doi.org/10.1111/j.1365-2044.1984.tb08895.x
  12. Brau ME, Sander F, Vogel W, Hempelmann G: Blocking mechanism of ketamine and its enantiomers in enzymatically demyelinated peripheral nerve as revealed by single channel experiments. Anesthesiology 1997; 86: 394-404. https://doi.org/10.1097/00000542-199702000-00014
  13. Hartrick CT, Wise JJ, Patterson JS: Preemptive intrathecal ketamine delays mechanical hyperalgesia in the neuropathic rat. Anesrh Analg 1997; 86: 557-60.
  14. Himmelseher S, Ziegler-Pirhamitsis D, Argiriadou H, Martin J, Jelen-Esselborn S: Small dose S(+ )-ketamine reduces postoperative pain when applied with ropivacaine in epidural anesthesia for total knee arthroplasty. Anesth Analg 2001; 92: 1290-5.
  15. Reiz S, Haggamark S, Johansson G, Nath S: Cardioroxicity of ropivacaine: a new amide local anesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93-8.
  16. Brockway MS, Bannister J, McClure JH, McKeown D, Wildsmith JAW: Comparison of extradural ropivacaine and bupivacaine. Br J Anaesth 1991; 66: 31-7. https://doi.org/10.1093/bja/66.1.31
  17. Finucane BT, Sandler AN, McKenna J, Reid D, Milner AL, Friedlander M, et al: A double-blind comparison of ropivacaine 0.5%, 0.75% 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy. Can J Anaesth 1996; 43: 442-9.
  18. Brodner G, Mertes N, Aken HV, Pogatzki E, Buerkle H, Marcus MA: Epidural analgesia with local anesthetics after abdominal surgery: Earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine. Anesth Analg 1999; 88: 128-33.
  19. Ora K, Namiki A, Iwasaki H, Takahashi I: Dose-related prolongation of tetracaine spinal anesthesia by oral clonidine in humans. Anesth Analg 1994; 79: 1121-5.
  20. Tverskoy M, Oren M, Vascovich M, Dashkovsky I, Kissin I: Ketamine enhances local anesthetic and analgesic effects of bupivacaine by peripheral mechanism: a study in postoperative patients. Neurosci Lett 1996; 215: 5-8. https://doi.org/10.1016/S0304-3940(96)12922-0
  21. Liu S, Chiu AA, Neal JM, Carpenter RL, Bainton BG, Gerancher JC: Oral clonidine prolongs lidocaine spinal anesthesia in human volunteers. Anesthesiology 1995; 82: 1353-9. https://doi.org/10.1097/00000542-199506000-00005
  22. Ramani S, Karnad AB: Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer, South Med J 1996; 89: 1101-3.
  23. Takahashi H, Miyazaki M, Nanbu T, Yanagida H, Morita S: The NMDA receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. Pain 1998; 75: 391-4. https://doi.org/10.1016/S0304-3959(97)00189-9
  24. Subramaniam K, Subramaniam B, Pawar DK, Kumar L: Evaluation of the safety and efficacy of epidural ketamine combined with morphine for postoperative analgesia in major upper abdominal surgery. J C1in Anesth 2001; 13: 339-44. https://doi.org/10.1016/S0952-8180(01)00278-1
  25. Lauretri GR, Oliveira AP, Rodrigues AM, Paccola CA: The effect of transdermal nitroglycerin on spinal S(+ )-ketamine anti-nociception following orthopedic surgery. J C1in Anesrh 2001; 13: 576-81. https://doi.org/10.1016/S0952-8180(01)00333-6